Inhaled form of interferon beta shows promise in COVID-19 treatment, maker says
Monday, July 20, 2020 - 17:40
in Health & Medicine
Interferon beta, a drug developed to treat asthma, reduces the risk for serious illness and the need for ventilator support in patients hospitalized with COVID-19, according to preliminary Phase 1 trial results.